Predicted Trait | |
Reported Trait | Prostate cancer |
Mapped Trait(s) | prostate carcinoma (EFO_0001663) |
Score Construction | |
PGS Name | GRS232_Eur |
Development Method | |
Name | Genome-wide significant SNPs |
Parameters | p<5E-08, r2<0.2 |
Variants | |
Original Genome Build | NR |
Number of Variants | 232 |
Effect Weight Type | log(OR) |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000379 |
Citation (link to publication) | Shi Z et al. Eur Urol Open Sci (2022) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 85.1% East Asian: 6.6% African: 6% Hispanic or Latin American: 2.4% 571,220 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST011049 Europe PMC: 33398198 |
177,526 individuals | European | NR |
GWAS Catalog: GCST011049 Europe PMC: 33398198 |
21,354 individuals | African American or Afro-Caribbean, African unspecified | NR |
GWAS Catalog: GCST011049 Europe PMC: 33398198 |
27,420 individuals | East Asian | NR |
GWAS Catalog: GCST011049 Europe PMC: 33398198 |
7,953 individuals | Hispanic or Latin American | NR |
GWAS Catalog: GCST002944 Europe PMC: 26034056 |
3,226 individuals | East Asian | CMHS, GERA, ProHealth, RPGEH |
Europe PMC: 19767752 |
[ ,
100.0 % Male samples |
European | UKGPCS |
GWAS Catalog: GCST000154 Europe PMC: 18264096 |
2,329 individuals | European | PLCO |
GWAS Catalog: GCST000153 Europe PMC: 18264098 |
23,226 individuals | European | ICR, IGD, deCODE |
GWAS Catalog: GCST006085 Europe PMC: 29892016 |
140,254 individuals | European | NR |
GWAS Catalog: GCST001942 Europe PMC: 23535732 |
22,548 individuals | European | NR |
GWAS Catalog: GCST002606 Europe PMC: 25217961 |
2,080 individuals | Hispanic or Latin American | NR |
GWAS Catalog: GCST002606 Europe PMC: 25217961 |
10,463 individuals | Sub-Saharan African, African American or Afro-Caribbean | NR |
GWAS Catalog: GCST002944 Europe PMC: 26034056 |
2,251 individuals | African American or Afro-Caribbean | CMHS, GERA, ProHealth, RPGEH |
GWAS Catalog: GCST002944 Europe PMC: 26034056 |
3,629 individuals | Hispanic or Latin American | CMHS, GERA, ProHealth, RPGEH |
GWAS Catalog: GCST002944 Europe PMC: 26034056 |
37,272 individuals | European | CMHS, GERA, ProHealth, RPGEH |
GWAS Catalog: GCST000017 Europe PMC: 17401363 |
2,329 individuals | European | NR |
— | [ ,
100.0 % Male samples |
European | 37 cohorts
|
GWAS Catalog: GCST002606 Europe PMC: 25217961 |
6,954 individuals | East Asian | NR |
GWAS Catalog: GCST002606 Europe PMC: 25217961 |
67,543 individuals | European | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM015506 | PSS009968| European Ancestry| 888,086 individuals |
PGP000379 | Shi Z et al. Eur Urol Open Sci (2022) |
Reported Trait: Prostate cancer | OR: 1.46 [1.45, 1.46] | — | — | age, 10 genetic PCs | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS009968 | — | 888,086 individuals, 100.0 % Male samples |
Median = 65.0 years | European | — | NR | — |